Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2023 06:33 ET | Source: Fortune Business Insights

CAR-T Cell Therapy Market Size to Surpass USD 14.42 Billion by 2030, exhibiting a CAGR of 18.5%

Pune, India, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Global CAR-T Cell Therapy Market Size was valued at USD 2.72 billion in 2022 and is projected to grow from USD 14.42 billion by 2030 exhibiting a CAGR...
September 20, 2023 09:27 ET | Source: Transparency Market Research

Global CAR T-cell Therapy Market is Anticipated to Reach US$ 21.8 Billion by 2031, Expanding at a 30.6% CAGR: TMR Report

Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The CAR T-cell therapy market was estimated to have acquired US$ 1.1 billion in 2020. It is anticipated to register a 30.6%...
July 31, 2023 06:00 ET | Source: Invectys, Inc.

FDA Grants Fast Track designation to IVS-3001, a CAR-T Cell Therapy in the Treatment of Renal Cell Carcinoma

Houston, TX, USA, July 31, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc., a clinical-stage immuno-oncology company focused on developing novel therapies for advanced cancers, is pleased to announce the...
April 14, 2023 05:34 ET | Source: Data Bridge Market Research

Chimeric Antigen Receptor (CAR)-T Cell Therapy Market to Exhibit an Incredible Growth of USD 5.35 Billion by 2030, Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis

NEW YORK, April 14, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Chimeric Antigen Receptor (CAR)-T Cell Therapy Market" with 100+ market data tables,...
January 25, 2023 21:15 ET | Source: Cell BioEngines, Inc.

Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer

BOSTON and NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines Inc. (the “Company”), a cell and gene therapy company focused on developing an allogenic cell-based product for solid tumors,...
April 20, 2021 20:50 ET | Source: DelveInsight Business Research LLP

Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight

Los Angeles, USA, April 20, 2021 (GLOBE NEWSWIRE) -- Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight More than 50% of trials investigating...
September 13, 2018 08:00 ET | Source: Crown Bioscience

CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer

SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...